ArticleOncoTargets and therapy2022

A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review.

Takahiro Fuji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.